Glaxo, Merck Mull Cross-Licensing Patents For Cervical Cancer Vaccines
U.K. drug maker GlaxoSmithKline PLC and German rival Merck & Co. Inc are in talks over a cross-licensing deal to share patents for cervical cancer vaccines at the center of a...To view the full article, register now.
Already a subscriber? Click here to view full article